13D Filing: K Equity, LLC and Kemet Corp (KEM)

The information in Item 6 of this
Third Amendment is incorporated herein by reference.

ITEM 6.   Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

 

Item 6 of the Schedule 13D
is hereby amended and supplemented, with effect from the date of this Third Amendment, by adding the following:

 

Additional Subsequent Events

On September 6, 2017, K Equity and the
Company entered into an underwriting agreement (the “Underwriting Agreement”) with UBS Securities LLC (the “Underwriter”).
Pursuant to the terms of the Underwriting Agreement, the Underwriter agreed to purchase from K Equity its common stock warrant,
dated May 31, 2011, to purchase 8,416,814 shares of common stock of the Company (the “Warrant”).

Pursuant to the Underwriting Agreement,
on September 11, 2017, K Equity sold the Warrant to the Underwriter for a price equal to $20.52 per share of underlying common
stock of the Company. As a result of the foregoing sale of the Warrant to the Underwriter, K Equity no longer beneficially owns
any shares of common stock of the Company on a post-sale basis.

The foregoing description of the Underwriting
Agreement is qualified in its entirety by reference to the full text thereof, which is included as Exhibit 8 hereto,
and is incorporated herein by reference.

ITEM 7.   Material to be Filed as Exhibits.

 

Item 7 of the Schedule 13D
is hereby amended and supplemented, with effect from the date of this Third Amendment, by adding the following:

 

Exhibit 8

Equity Underwriting Agreement, dated September 6, 2017, by and among K Equity, the Company and UBS Securities LLC (incorporated by reference to Exhibit 1.1 of the Current Report on Form 8-K filed by the Company with the SEC on September 8, 2017).